Helmerich & Payne (HP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 May, 2026Executive summary
Delivered resilient Q2 2026 results amid Middle East conflict, maintaining operational continuity and safety focus, with a new CEO appointed in March 2026.
Adjusted EBITDA was $178M, with revenues of $932M, and net loss of $59M ($0.59 per share), including $26M in non-cash impairment; adjusted net loss was $38M ($0.38 per share).
Successfully closed the Utica Square sale, generating after-tax proceeds exceeding $100M, enabling early repayment of a $400M term loan and strengthening the balance sheet.
North America Solutions (NAS) averaged 136 rigs, slightly ahead of expectations, with strong technology adoption and margin leadership.
Offshore segment outperformed, securing a major BP contract extension in the Caspian Sea and benefiting from long-term contracts.
Financial highlights
Q2 2026 revenue was $932M, adjusted EBITDA $178M (19% margin), and net loss $59M; adjusted EPS was $(0.38).
Free cash flow was negative due to timing of receivables, but $74M excluding working capital changes.
CapEx for Q2 was $52M–$63M, trending below anticipated levels due to reclassification and capital efficiency.
Cash and cash equivalents at quarter-end were $177M, with total liquidity of $1.1B including undrawn credit facility.
Net debt reduced by $400M following early retirement of the term loan.
Outlook and guidance
NAS Q3 direct margins expected at $230M–$240M, with rig count guidance raised to 137–144 for the year.
International Solutions Q3 rig count expected at 58–68; direct margin guidance $12M–$32M, with $6M impact from supply chain constraints if Strait of Hormuz remains closed.
Offshore Q3 direct margin guidance: $24M–$28M; full-year guidance $100M–$115M.
FY26 gross capital expenditures projected at $270M–$310M.
Free cash flow conversion for the year expected at ~30%, rising to 40%–45% by 2027–2028.
Latest events from Helmerich & Payne
- Q1 2026 posted $1.02B revenue, $230M EBITDA, and a $97M net loss from $103M in impairments.HP
Q1 202621 Apr 2026 - All board proposals passed with strong support, marking a smooth CEO transition.HP
AGM 20264 Mar 2026 - $1.97B KCA Deutag deal creates a global leader, boosts cash flow, and expands international scale.HP
Q3 20243 Feb 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.HP
Proxy Filing22 Jan 2026 - Shareholders to vote on board, auditor, executive pay, and expanded incentive plan amid strong results.HP
Proxy Filing22 Jan 2026 - Strong FY24, global expansion via KCA Deutag, and lower 2025 CapEx to drive cash flow.HP
Q4 202414 Jan 2026 - KCA Deutag acquisition expands global scale as Q1 profit drops on higher costs.HP
Q1 202517 Dec 2025 - 2024 saw robust results, global growth, and strong governance, with all board proposals recommended.HP
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect directors, approve pay, and ratify auditors in March 2025.HP
Proxy Filing1 Dec 2025